[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1074 Introduced in House (IH)]
113th CONGRESS
1st Session
H. R. 1074
To amend the Public Health Service Act to foster more effective
implementation and coordination of clinical care for people with pre-
diabetes and diabetes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
March 12, 2013
Mr. Olson (for himself, Mr. Moran, Mr. Sessions, Mr. Roe of Tennessee,
Mr. Maffei, and Ms. Tsongas) introduced the following bill; which was
referred to the Committee on Energy and Commerce
_______________________________________________________________________
A BILL
To amend the Public Health Service Act to foster more effective
implementation and coordination of clinical care for people with pre-
diabetes and diabetes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``National Diabetes Clinical Care
Commission Act''.
SEC. 2. FINDINGS.
Congress finds the following:
(1) The Centers for Disease Control and Prevention report
that nearly 26,000,000 Americans have diabetes in addition to
an estimated 79,000,000 American adults that have pre-diabetes,
an increase of 2,000,000 Americans with diabetes and 22,000,000
American adults with pre-diabetes since 2008.
(2) Diabetes affects 8.3 percent of Americans of all ages
and 11.3 percent of adults age 20 and older. Individuals of
racial and ethnic minorities continue to have higher rates of
diabetes than individuals not of such minorities, as
demonstrated by the following: 16.1 percent of all adult
American Indians and Alaskan Natives have diabetes; 12.6
percent of all adult African-Americans have diabetes; 11.8
percent of all adult Hispanics have diabetes; and 8.4 percent
of all adult Asian-Americans have diabetes, while 7.1 percent
of all non-Hispanic Whites have diabetes.
(3) Diabetes is the seventh leading cause of death in the
United States.
(4) People with diabetes are more likely than people
without diabetes to have heart attacks, strokes, high blood
pressure, kidney failure, blindness, and require amputations.
(5) Total national costs associated with diabetes in 2007
exceeded $174,000,000,000, according to the Centers for Disease
Control and Prevention.
(6) One in three Medicare dollars is currently spent on
people with diabetes.
(7) The Centers for Disease Control and Prevention projects
that as many as 1 in 3 American adults could have diabetes by
2050 if current trends continue.
(8) There are 35 Federal departments, agencies, and offices
involved in the implementation of Federal diabetes activities.
SEC. 3. ESTABLISHMENT OF THE NATIONAL DIABETES CLINICAL CARE
COMMISSION.
Part P of title III of the Public Health Service Act (42 U.S.C.
280g et seq.) is amended by adding at the end the following new
section:
``SEC. 399V-6. NATIONAL DIABETES CLINICAL CARE COMMISSION.
``(a) Establishment.--There is hereby established within the
Department of Health and Human Services the National Diabetes Clinical
Care Commission (in this section referred to as the `Commission') to
evaluate and make recommendations regarding better coordination and
leveraging of programs within the Department of Health and Human
Services and other Federal agencies that relate in any way to
supporting appropriate clinical care (such as any interactions between
physicians and other health care providers and their patients with pre-
diabetes and diabetes where care is rendered for the management of
their pre-diabetes or diabetes or its complications) for people with
pre-diabetes and diabetes.
``(b) Membership.--
``(1) In general.--The Commission shall be composed of the
following voting members:
``(A) The heads (or their designees) of the
following Federal agencies and departments that conduct
programs that could impact the clinical care of people
with pre-diabetes and diabetes:
``(i) The Centers for Medicare and Medicaid
Services.
``(ii) The Agency for Healthcare Research
and Quality.
``(iii) The Centers for Disease Control and
Prevention.
``(iv) The Indian Health Service.
``(v) The Department of Veterans Affairs.
``(vi) The National Institutes of Health.
``(vii) The Food and Drug Administration.
``(viii) The Health Resources and Services
Administration.
``(ix) The Department of Defense.
``(x) Other governmental or nongovernmental
agency heads, at the discretion of the agency,
that impact clinical care of individuals with
pre-diabetes and diabetes.
``(B) Twelve additional voting members appointed
under paragraph (2).
``(2) Additional members.--The Commission shall include
additional voting members appointed by the Comptroller General
of the United States, in consultation with national medical
societies and patient advocate organizations with expertise in
diabetes and the care of patients with diabetes, including one
or more from each of the following categories:
``(A) Clinical endocrinologists.
``(B) Physician specialties (other than as
described in subparagraph (A)) that play a role in
diabetes care or their complications.
``(C) Primary care physicians.
``(D) Non-physician health care professionals, such
as certified diabetes educators, clinical dieticians,
nurses, nurse practitioners, and physician assistants.
``(E) Patient advocates.
``(F) National experts in the duties listed under
subsection (c).
``(3) Chairperson.--The voting members of the Commission
shall select a chairperson from the members described in
paragraph (2)(A).
``(4) Meetings.--The Commission shall meet at least twice,
and not more than 4 times, a year.
``(5) Board terms.--Members of the Commission, including
the chairperson, shall serve for a 3-year term. A vacancy on
the Commission shall be filled in the same manner as the
original appointments.
``(c) Duties.--The Commission shall--
``(1) evaluate programs of the Department of Health and
Human Services regarding the utilization of diabetes screening
benefits, annual wellness visits, and other preventive health
benefits that may reduce the risk of diabetes and its
complications, addressing any existing problems regarding such
utilization and related data collection mechanisms;
``(2) identify current activities and critical gaps in
Federal efforts to support clinicians in providing integrated,
high-quality care to people with pre-diabetes and diabetes;
``(3) make recommendations regarding the coordination of
clinically based activities that are being supported by the
Federal Government;
``(4) make recommendations regarding the development and
coordination of federally funded clinical practice support
tools for physicians and other health care professionals in
caring for and managing the care of people with pre-diabetes
and diabetes;
``(5) evaluate programs in existence as of the date of the
enactment of this section and determine if such programs are
meeting the needs identified in paragraph (2) and, if such
programs are determined to not be meeting such needs, recommend
programs that would be more appropriate;
``(6) recommend how an outcomes-based registry may be
developed and then used to evaluate various care models and
methods and the impact of such models and methods on diabetes
management as measured by appropriate care parameters (such as
A1C, blood pressure, and cholesterol levels);
``(7) evaluate and expand education and awareness to
physicians and other health care professionals regarding
clinical practices for the prevention of diabetes and the
precursor conditions of diabetes;
``(8) review and recommend appropriate methods for outreach
and dissemination of educational resources that regard diabetes
prevention and treatments, are funded by the Federal
Government, and are intended for health care professionals and
the public; and
``(9) include other activities, such as those relating to
the areas of public health and nutrition, that the Commission
deems appropriate.
``(d) Operating Plan.--
``(1) Initial plan.--Not later than 90 days after its first
meeting, the Commission shall submit to the Secretary and the
Congress an operating plan for carrying out the activities of
the Commission as described in subsection (c). Such operating
plan may include--
``(A) a list of specific activities that the
Commission plans to conduct for purposes of carrying
out the duties described in each of the paragraphs in
subsection (c);
``(B) a plan for completing the activities;
``(C) a list of members of the Commission and other
individuals who are not members of the Commission who
will need to be involved to conduct such activities;
``(D) an explanation of Federal agency involvement
and coordination needed to conduct such activities;
``(E) a budget for conducting such activities;
``(F) a plan for evaluating the value and potential
impact of the Commission's work and recommendations,
including the possible continuation of the Commission
for the purposes of overseeing their implementation;
and
``(G) other information that the Commission deems
appropriate.
``(2) Updates.--The Commission shall periodically update
the operating plan under paragraph (1) and submit such updates
to the Secretary and the Congress.
``(e) Final Report and Sunset of the Commission.--By not later than
3 years after the date of the Commission's first meeting, the
Commission shall submit to the Secretary and the Congress a report
containing all of the findings and recommendations of the Commission.
Not later than 120 days after the submission of the final report, the
Secretary shall review the evaluation required under subsection
(d)(1)(F) to determine the continuation of the Commission.
``(f) Authorization of Appropriations.--Appropriations are
authorized to be made available to the Commission for each of fiscal
years 2013, 2014, and 2015, from amounts otherwise made available to
the Department of Health and Human Services for such fiscal years, to
carry out this section.''.
<all>